Sinovac | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Monday
May 19, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
MONDAY, MAY 19, 2025

Sinovac

Chinese Sinovac scraps Tk5,000cr investment, cites approval delay
Health

Chinese Sinovac scraps Tk5,000cr investment, cites approval delay

A senior Sinovac official told The Business Standard that the company pulled out due to delays in project approval. However, other sources said the company withdrew its project due to a lack of...

Sinovac to invest Tk5,000cr in plasma-based medicines
Health

Sinovac to invest Tk5,000cr in plasma-based medicines

The Sinovac vaccine is pictured at StarMed Specialist Centre, a private medical centre, in Singapore July 13, 2021. Photo :Reuters
Coronavirus chronicle

Sinovac Covid-19 shot with Pfizer booster less effective against Omicron - study

UK to add China's Sinovac, India's Covaxin to approved vaccine list
Coronavirus chronicle

UK to add China's Sinovac, India's Covaxin to approved vaccine list

One million doses of Sinovac vaccine arrive in Dhaka
Covid-19 in Bangladesh

One million doses of Sinovac vaccine arrive in Dhaka

A health worker holds a syringe and a vial of the Sinovac coronavirus disease (Covid-19) vaccine at a market in Bangkok, Thailand, March 17, 2021. Photo :Reuters
Coronavirus chronicle

Thailand to cease Sinovac vaccine use when stocks end this month

Malaysia approves Sinovac's Covid-19 vaccine for ages 12 to 17
Coronavirus chronicle

Malaysia approves Sinovac's Covid-19 vaccine for ages 12 to 17

Photo: Collected
Bangladesh

Bangladesh approves Sinovac Covid-19 vaccine for emergency use

Photo: Sumit Dayal/Bloomberg
Bangladesh

Bangladesh starts administering Sinopharm vaccine

A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter
Coronavirus chronicle

EU drug regulator begins real-time review of Sinovac's Covid-19 vaccine

FILE PHOTO: An employee holds a vial containing CoronaVac, Sinovac Biotech's vaccine against the coronavirus disease (COVID-19), at Butantan biomedical production center in Sao Paulo, Brazil January 12, 2021. REUTERS/Amanda Perobelli
Coronavirus chronicle

Sinovac vaccine 80 pct effective against Covid-19-related death: Chilean gov’t study

Dispensed vials of the Sinovac COVID-19 vaccine are seen as the Thai resort island of Phuket rushes to vaccinate its population amid the coronavirus disease (COVID-19) outbreak, and ahead of a July 1 ending of strict quarantine for overseas visitors, to bring back tourism revenue in Phuket, Thailand, April 1, 2021. REUTERS/Jorge Silva
Coronavirus chronicle

China’s Sinovac Covid-19 vaccine 67% effective in preventing symptomatic infection - Chile govt report

A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. /Reuters
Coronavirus chronicle

Sinovac vaccine effective in children

  • Show More
  • loading...
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net